Fecal microbiota transplantation donation : the gift that keeps on giving
Copyright © 2019 Elsevier Ltd. All rights reserved..
Fecal microbiota transplantation (FMT) is being studied and utilized for various medical conditions including Clostridium difficile colitis, inflammatory bowel diseases (IBD), obesity, myasthenia gravis, and so on. Yet, FMT donation, whether from an individual or a stool bank, can be challenging given the numerous requirements and donor costs. Furthermore, data outcomes on recipients of FMT regarding donor's health co-morbidities, age, and weight are limited but emerging. The purpose of this review is to evaluate cost, safety, and accessibility in FMT donation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Current opinion in pharmacology - 49(2019) vom: 20. Dez., Seite 24-28 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Turse, Erica P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 30.09.2020 Date Revised 30.09.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.coph.2019.04.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM297042459 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM297042459 | ||
| 003 | DE-627 | ||
| 005 | 20231225091137.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.coph.2019.04.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0990.xml |
| 035 | |a (DE-627)NLM297042459 | ||
| 035 | |a (NLM)31085417 | ||
| 035 | |a (PII)S1471-4892(18)30156-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Turse, Erica P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fecal microbiota transplantation donation |b the gift that keeps on giving |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.09.2020 | ||
| 500 | |a Date Revised 30.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Ltd. All rights reserved. | ||
| 520 | |a Fecal microbiota transplantation (FMT) is being studied and utilized for various medical conditions including Clostridium difficile colitis, inflammatory bowel diseases (IBD), obesity, myasthenia gravis, and so on. Yet, FMT donation, whether from an individual or a stool bank, can be challenging given the numerous requirements and donor costs. Furthermore, data outcomes on recipients of FMT regarding donor's health co-morbidities, age, and weight are limited but emerging. The purpose of this review is to evaluate cost, safety, and accessibility in FMT donation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Dailey, Francis E |e verfasserin |4 aut | |
| 700 | 1 | |a Ghouri, Yezaz A |e verfasserin |4 aut | |
| 700 | 1 | |a Tahan, Veysel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in pharmacology |d 2001 |g 49(2019) vom: 20. Dez., Seite 24-28 |w (DE-627)NLM116029935 |x 1471-4973 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2019 |g day:20 |g month:12 |g pages:24-28 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.coph.2019.04.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2019 |b 20 |c 12 |h 24-28 | ||